Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2095219 Target Snapshot

Muscarinic acetylcholine receptors; M1 & M2 · SELECTIVITY GROUP · Homo sapiens

660Compounds
56Assays
1Approved Drugs
281.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P11229. Use UniProt P11229 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P11229 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Muscarinic acetylcholine receptors; M1 & M2 as ChEMBL target CHEMBL2095219, mapped to UniProt P11229. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Muscarinic acetylcholine receptors; M1 & M2
SELECTIVITY GROUP · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2095219
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P11229
Muscarinic acetylcholine receptor M1
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Muscarinic acetylcholine receptors; M1 & M2 is the right protein anchor across sources, using UniProt P11229 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelMuscarinic acetylcholine receptor M1
UniProt AccessionP11229
Component TypeProtein
Sequence Length460 aa

Muscarinic acetylcholine receptor M1

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Muscarinic acetylcholine receptors; M1 & M2, mapped to UniProt P11229. ChEMBL maps the protein component as Muscarinic acetylcholine receptor M1. Sequence length is 460 aa.

Mapped IDP11229
Review nameMuscarinic acetylcholine receptors; M1 & M2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50279.0
KI2.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL287868 9.55 Ki 0.279 Preclinical
CHEMBL517712 9.17 Ki 0.683 Approved
CHEMBL6001460 7.7 IC50 20.0 Preclinical
CHEMBL5941178 7.52 IC50 30.0 Preclinical
CHEMBL6001161 7.52 IC50 30.0 Preclinical
CHEMBL5777432 7.4 IC50 40.0 Preclinical
CHEMBL5958580 7.4 IC50 40.0 Preclinical
CHEMBL5763957 7.3 IC50 50.0 Preclinical
CHEMBL5835409 7.3 IC50 50.0 Preclinical
CHEMBL5987707 7.3 IC50 50.0 Preclinical
Distribution

pChEMBL Value Distribution

0
5.0
0
5.5
88
6.0
121
6.5
67
7.0
3
7.5
0
8.0
0
8.5
1
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

ATROPINE
CHEMBL517712
Approved 1960
Assay Landscape

Assay Landscape

56
Total Assays
270
Tested Compounds
3
Assay Types
Binding — 52 assays, 270 compounds
BAO Format Assays Compounds Avg pChEMBL
protein format 32 268 6.7
cell-based format 9 0
assay format 8 0
tissue-based format 3 2 9.4
Functional — 3 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 3 0
ADME — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine